TAU-ANNONACIN · Effects of systemic annonacin exposure in transgenic mice expressing normal or mutant human tau protein: role of environment-gene interactions in neurodegeneration
FP6 — Marie Curie Actions (Human Resources and Mobility)
- Duration
- 2006-01-01 → 2007-12-31
- EU contribution
- €213,522
- Participants
- 1
- Scheme
- IIF
Lines connect the coordinator with its partners.
Results in brief
Final Activity Report Summary - TAU-ANNONACIN (Effects of systemic annonacin exposure in transgenic mice expressing normal or mutant human tau protein: role of environment-gene interactions ...)
Experimental and epidemiological studies have identified natural substances, such as the acetogenin annonacin, which could be associated with mechanisms of neurodegeneration in some forms of tauopathies (Champy et al., 2004). Many mutations in the tau gene have also been associated with familial cases of tauopathies, such as the frontotemporal dementias with parkinsonism linked to chromosome 17 (FTDP-17) (Lee et al., 2001). However, the relative contribution of genetic and environmental factors to the observed neurodegenerative changes and the way in which specific genetic backgrounds affect the susceptibility towards the exposure to environmental toxins are still unclear. The goal of this proposal was to investigate gene-environment interactions using experimental models of tau-associated neurodegeneration. We proposed to determine whether there was a pathogenetic synergy between annonacin intoxication and mutations in the tau gene that led to FTDP-17. We used transgenic mice bearing specific genetic backgrounds (Lee et al., 2005) to study the effects of annonacin, a natural mitochondrial toxin that inhibited complex I, on the tau protein. We found that annonacin exposure caused an increase in the number of neurons with phosphorylated tau in the somatodendritic compartment in several brain areas, with such an effect being only observed in mice that expressed a mutated human tau (R406W mutation) as opposed to mice that either overexpressed the wild-type human tau (hWT +/-) or had only the endogenous mouse tau (hWT -/-). We also found evidence suggestive that the annonacin effect was at least partly mediated through a proteasome dysfunction. In summary, we found a synergistic interaction between annonacin exposure and the presence of an FTDP-17 mutation that resulted in increased phosphorylation of neuronal tau.
Data: CORDIS, © European Union
Project objective
Experimental and epidemiological studies have identified natural substances, such as the acetogenin annonacin, that could be associated with mechanisms of neurodegeneration in some forms of tauopathies. Many mutations in the tau gene have also been associa ted with familial cases of tauopathies, such as the frontotemporal dementias with parkinsonism linked to chromosome 17 (FTDP-17). However, it is still not clear what is the relative contribution of genetic and environmental factors to the observed neurodeg enerative changes (neuronal loss and pathological tau aggregation) and how specific genetic backgrounds affect the susceptibility towards the exposure to environmental toxins. The goal of this proposal is to investigate gene-environment interactions using experimental models of Tau-associated neurodegeneration. We propose to determine whether there is a pathogenetic synergy between annonacin intoxication and mutations in the tau gene that lead to FTDP-17. Our proposal will take advantage of the transgenic mouse technology to study the effects of a natural toxin on animal models bearing specific genetic background. The results obtained may also increase our understanding of physiopathogenic mechanisms of major neurodegenerative diseases where a gene-environm ent interaction appears to play a role as is the case of Parkinson's and Alzheimer¿s diseases. The proposed research project has emerged from a consortium of three groups in Europe (Germany, France, Guadeloupe) in cooperation with an experienced researcher from a developing country (Brazil). The realization of the proposed work will strongly strengthen the infrastructure of cooperation between the European partners and will contribute to the human capacity building in the area of neurodegeneration in Brazil .
Original text from CORDIS.
Participants
- PHILIPPS-UNIVERSITAET MARBURG · MARBURGCoordinatorGermany
Links
Data: CORDIS, © European Union
